12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga·10/13/2025 12:08:59
Listen to the news
Gainers
- ENDRA Life Sciences (NASDAQ:NDRA) stock rose 45.8% to $9.45 during Monday's pre-market session. The company's market cap stands at $4.8 million.
- Aclarion (NASDAQ:ACON) shares rose 34.34% to $11.55. The market value of their outstanding shares is at $5.0 million.
- Forian (NASDAQ:FORA) stock increased by 19.48% to $2.76. The company's market cap stands at $71.8 million.
- rYojbaba (NASDAQ:RYOJ) shares rose 15.97% to $2.25. The company's market cap stands at $21.8 million.
- Nanobiotix (NASDAQ:NBTX) shares increased by 15.84% to $27.34. The market value of their outstanding shares is at $1.1 billion.
- Predictive Oncology (NASDAQ:POAI) stock moved upwards by 15.55% to $16.05. The market value of their outstanding shares is at $10.5 million.
Losers
- Tvardi Therapeutics (NASDAQ:TVRD) shares declined by 88.0% to $5.0 during Monday's pre-market session. The market value of their outstanding shares is at $390.1 million.
- Catheter Precision (AMEX:VTAK) stock fell 15.95% to $2.32. The market value of their outstanding shares is at $4.1 million.
- Aditxt (NASDAQ:ADTX) stock decreased by 15.92% to $0.51. The market value of their outstanding shares is at $2.9 million.
- Quoin Pharmaceuticals (NASDAQ:QNRX) shares fell 12.69% to $17.9. The company's market cap stands at $12.0 million.
- Bluejay Diagnostics (NASDAQ:BJDX) stock fell 12.23% to $2.8. The company's market cap stands at $4.7 million.
- Ensysce Biosciences (NASDAQ:ENSC) shares fell 11.12% to $2.0. The company's market cap stands at $6.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.